絞り込み

16731

広告

Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.

著者 Li XM , Sun SG , Zhang WD
Chin Med J (Engl).2012 Jul ; 125(13):2339-45.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Pharmacy, the Military General Hospital of Beijing PLA, Beijing 100700, China (Email: lixiuminpla@yahoo.cn).

スターを付ける スターを付ける     (103view , 0users)

Full Text Sources

Medical

Enoxaparin is routinely used for prevention of venous thromboembolism (VTE) after total hip or knee arthroplasty. The purpose of this study was to compare the efficacy and safety of apixaban, a newly oral direct inhibitor of factor Xa versus enoxaparin.
PMID: 22882859 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード